5
Clinical Trials associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium / Active, not recruitingNot Applicable Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia: a Multi-center-database Real-world Study
This study is a large-scale, prospective, multi-center, and non-interventional observation study to observe blood pressure and blood lipid changes and safety during administration of olomax tablets for 24 weeks in hypertensive patients with dyslipidemia.
A Multi-center, Randomized, Open-label, Active-controlled, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
The purpose of this study is to evaluate the efficacy and safety of OLOMAX Tab (20/5/5mg, 20/5/10mg) in Hypertension Patients with Low-Intermediate Risk for Cardiovascular Disease.
An Open-label, Randomized, 2X2 Crossover Study to Compare the Pharmacokinetics and Safety Between DWJ1351 and Co-administration of Amlodipine/Olmesartan and Rosuvastatin in Healthy Male Subjects
The purpose of this study is to compare the safety and pharmacokinetic characteristics of combination of amlodipine, olmesartan and rosuvastatin and DWJ1351 in healthy male volunteers
100 Clinical Results associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Translational Medicine associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Patents (Medical) associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Deals associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium